Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 98 Pages
Report ld: 3497329
Request Sample
Customized Report
Left Atrial Appendage Occluder System Market Size(US$)

CAGR 2025-2031
4.7%
Market Size,2031
USD 474
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Left Atrial Appendage Occluder System was estimated to be worth US$ 345 million in 2024 and is forecast to a readjusted size of US$ 474 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
A Left Atrial Appendage Occluder System is a medical device used in the treatment of atrial fibrillation (AFib) to prevent blood clots from forming in the left atrial appendage of the heart. These devices are implanted to reduce the risk of stroke in patients with AFib who cannot tolerate long-term anticoagulation therapy.
Left Atrial Appendage Occluder Systems are designed to seal off the left atrial appendage, a small pouch-like structure in the heart where blood clots can form in patients with AFib. By closing off this area, the occluder system reduces the risk of blood clots breaking loose and causing a stroke.
Manufacturers are focusing on developing LAAO devices that can be implanted using minimally invasive techniques, reducing procedural complexity and patient recovery time.
There is ongoing research and clinical trials to expand the indications for LAAO systems to include patients with non-valvular AFib and those with contraindications to anticoagulation therapy.
This report aims to provide a comprehensive presentation of the global market for Left Atrial Appendage Occluder System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Left Atrial Appendage Occluder System by region & country, by Type, and by Application.
The Left Atrial Appendage Occluder System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Left Atrial Appendage Occluder System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Left Atrial Appendage Occluder System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Left Atrial Appendage Occluder System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Left Atrial Appendage Occluder System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Left Atrial Appendage Occluder System Product Introduction
1.2 Global Left Atrial Appendage Occluder System Market Size Forecast
1.2.1 Global Left Atrial Appendage Occluder System Sales Value (2020-2031)
1.2.2 Global Left Atrial Appendage Occluder System Sales Volume (2020-2031)
1.2.3 Global Left Atrial Appendage Occluder System Sales Price (2020-2031)
1.3 Left Atrial Appendage Occluder System Market Trends & Drivers
1.3.1 Left Atrial Appendage Occluder System Industry Trends
1.3.2 Left Atrial Appendage Occluder System Market Drivers & Opportunity
1.3.3 Left Atrial Appendage Occluder System Market Challenges
1.3.4 Left Atrial Appendage Occluder System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Left Atrial Appendage Occluder System Players Revenue Ranking (2024)
2.2 Global Left Atrial Appendage Occluder System Revenue by Company (2020-2025)
2.3 Global Left Atrial Appendage Occluder System Players Sales Volume Ranking (2024)
2.4 Global Left Atrial Appendage Occluder System Sales Volume by Company Players (2020-2025)
2.5 Global Left Atrial Appendage Occluder System Average Price by Company (2020-2025)
2.6 Key Manufacturers Left Atrial Appendage Occluder System Manufacturing Base and Headquarters
2.7 Key Manufacturers Left Atrial Appendage Occluder System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Left Atrial Appendage Occluder System
2.9 Left Atrial Appendage Occluder System Market Competitive Analysis
2.9.1 Left Atrial Appendage Occluder System Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Left Atrial Appendage Occluder System Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left Atrial Appendage Occluder System as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diameter 21mm
3.1.2 Diameter 24mm
3.1.3 Diameter 27mm
3.1.4 Diameter 30mm
3.1.5 Diameter 33mm
3.2 Global Left Atrial Appendage Occluder System Sales Value by Type
3.2.1 Global Left Atrial Appendage Occluder System Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Left Atrial Appendage Occluder System Sales Value, by Type (2020-2031)
3.2.3 Global Left Atrial Appendage Occluder System Sales Value, by Type (%) (2020-2031)
3.3 Global Left Atrial Appendage Occluder System Sales Volume by Type
3.3.1 Global Left Atrial Appendage Occluder System Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Left Atrial Appendage Occluder System Sales Volume, by Type (2020-2031)
3.3.3 Global Left Atrial Appendage Occluder System Sales Volume, by Type (%) (2020-2031)
3.4 Global Left Atrial Appendage Occluder System Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Specialist Clinic
4.1.3 Others
4.2 Global Left Atrial Appendage Occluder System Sales Value by Application
4.2.1 Global Left Atrial Appendage Occluder System Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Left Atrial Appendage Occluder System Sales Value, by Application (2020-2031)
4.2.3 Global Left Atrial Appendage Occluder System Sales Value, by Application (%) (2020-2031)
4.3 Global Left Atrial Appendage Occluder System Sales Volume by Application
4.3.1 Global Left Atrial Appendage Occluder System Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Left Atrial Appendage Occluder System Sales Volume, by Application (2020-2031)
4.3.3 Global Left Atrial Appendage Occluder System Sales Volume, by Application (%) (2020-2031)
4.4 Global Left Atrial Appendage Occluder System Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Left Atrial Appendage Occluder System Sales Value by Region
5.1.1 Global Left Atrial Appendage Occluder System Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Left Atrial Appendage Occluder System Sales Value by Region (2020-2025)
5.1.3 Global Left Atrial Appendage Occluder System Sales Value by Region (2026-2031)
5.1.4 Global Left Atrial Appendage Occluder System Sales Value by Region (%), (2020-2031)
5.2 Global Left Atrial Appendage Occluder System Sales Volume by Region
5.2.1 Global Left Atrial Appendage Occluder System Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Left Atrial Appendage Occluder System Sales Volume by Region (2020-2025)
5.2.3 Global Left Atrial Appendage Occluder System Sales Volume by Region (2026-2031)
5.2.4 Global Left Atrial Appendage Occluder System Sales Volume by Region (%), (2020-2031)
5.3 Global Left Atrial Appendage Occluder System Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Left Atrial Appendage Occluder System Sales Value, 2020-2031
5.4.2 North America Left Atrial Appendage Occluder System Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Left Atrial Appendage Occluder System Sales Value, 2020-2031
5.5.2 Europe Left Atrial Appendage Occluder System Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Left Atrial Appendage Occluder System Sales Value, 2020-2031
5.6.2 Asia Pacific Left Atrial Appendage Occluder System Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Left Atrial Appendage Occluder System Sales Value, 2020-2031
5.7.2 South America Left Atrial Appendage Occluder System Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Left Atrial Appendage Occluder System Sales Value, 2020-2031
5.8.2 Middle East & Africa Left Atrial Appendage Occluder System Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Left Atrial Appendage Occluder System Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Left Atrial Appendage Occluder System Sales Value
6.2.1 Key Countries/Regions Left Atrial Appendage Occluder System Sales Value, 2020-2031
6.2.2 Key Countries/Regions Left Atrial Appendage Occluder System Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Left Atrial Appendage Occluder System Sales Value, 2020-2031
6.3.2 United States Left Atrial Appendage Occluder System Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Left Atrial Appendage Occluder System Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Left Atrial Appendage Occluder System Sales Value, 2020-2031
6.4.2 Europe Left Atrial Appendage Occluder System Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Left Atrial Appendage Occluder System Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Left Atrial Appendage Occluder System Sales Value, 2020-2031
6.5.2 China Left Atrial Appendage Occluder System Sales Value by Type (%), 2024 VS 2031
6.5.3 China Left Atrial Appendage Occluder System Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Left Atrial Appendage Occluder System Sales Value, 2020-2031
6.6.2 Japan Left Atrial Appendage Occluder System Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Left Atrial Appendage Occluder System Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Left Atrial Appendage Occluder System Sales Value, 2020-2031
6.7.2 South Korea Left Atrial Appendage Occluder System Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Left Atrial Appendage Occluder System Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Left Atrial Appendage Occluder System Sales Value, 2020-2031
6.8.2 Southeast Asia Left Atrial Appendage Occluder System Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Left Atrial Appendage Occluder System Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Left Atrial Appendage Occluder System Sales Value, 2020-2031
6.9.2 India Left Atrial Appendage Occluder System Sales Value by Type (%), 2024 VS 2031
6.9.3 India Left Atrial Appendage Occluder System Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abbott Left Atrial Appendage Occluder System Product Offerings
7.1.5 Abbott Recent Development
7.2 Boston Scientific
7.2.1 Boston Scientific Company Information
7.2.2 Boston Scientific Introduction and Business Overview
7.2.3 Boston Scientific Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Boston Scientific Left Atrial Appendage Occluder System Product Offerings
7.2.5 Boston Scientific Recent Development
7.3 Coherex Medical
7.3.1 Coherex Medical Company Information
7.3.2 Coherex Medical Introduction and Business Overview
7.3.3 Coherex Medical Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Coherex Medical Left Atrial Appendage Occluder System Product Offerings
7.3.5 Coherex Medical Recent Development
7.4 Conformal Medical
7.4.1 Conformal Medical Company Information
7.4.2 Conformal Medical Introduction and Business Overview
7.4.3 Conformal Medical Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Conformal Medical Left Atrial Appendage Occluder System Product Offerings
7.4.5 Conformal Medical Recent Development
7.5 Eclipse Medical
7.5.1 Eclipse Medical Company Information
7.5.2 Eclipse Medical Introduction and Business Overview
7.5.3 Eclipse Medical Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Eclipse Medical Left Atrial Appendage Occluder System Product Offerings
7.5.5 Eclipse Medical Recent Development
7.6 Occlutech
7.6.1 Occlutech Company Information
7.6.2 Occlutech Introduction and Business Overview
7.6.3 Occlutech Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Occlutech Left Atrial Appendage Occluder System Product Offerings
7.6.5 Occlutech Recent Development
7.7 Lepu Medical
7.7.1 Lepu Medical Company Information
7.7.2 Lepu Medical Introduction and Business Overview
7.7.3 Lepu Medical Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Lepu Medical Left Atrial Appendage Occluder System Product Offerings
7.7.5 Lepu Medical Recent Development
7.8 Shanghai Push Medical
7.8.1 Shanghai Push Medical Company Information
7.8.2 Shanghai Push Medical Introduction and Business Overview
7.8.3 Shanghai Push Medical Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Shanghai Push Medical Left Atrial Appendage Occluder System Product Offerings
7.8.5 Shanghai Push Medical Recent Development
7.9 HeartCare
7.9.1 HeartCare Company Information
7.9.2 HeartCare Introduction and Business Overview
7.9.3 HeartCare Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 HeartCare Left Atrial Appendage Occluder System Product Offerings
7.9.5 HeartCare Recent Development
7.10 Lifetech Scientific
7.10.1 Lifetech Scientific Company Information
7.10.2 Lifetech Scientific Introduction and Business Overview
7.10.3 Lifetech Scientific Left Atrial Appendage Occluder System Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Lifetech Scientific Left Atrial Appendage Occluder System Product Offerings
7.10.5 Lifetech Scientific Recent Development
8 Industry Chain Analysis
8.1 Left Atrial Appendage Occluder System Industrial Chain
8.2 Left Atrial Appendage Occluder System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Left Atrial Appendage Occluder System Sales Model
8.5.2 Sales Channel
8.5.3 Left Atrial Appendage Occluder System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Left Atrial Appendage Occluder System was estimated to be worth US$ 360 million in 2025 and is projected to reach US$ 494 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 128
USD 3950.00
(Single User License)
The global Left Atrial Appendage Occluder System market was valued at US$ 360 million in 2025 and is anticipated to reach US$ 494 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 111
USD 2900.00
(Single User License)
The global Left Atrial Appendage Occluder System market size was US$ 345 million in 2024 and is forecast to a readjusted size of US$ 474 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
The global Left Atrial Appendage Occluder System market is projected to grow from US$ 345 million in 2024 to US$ 474 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 146
USD 4900.00
(Single User License)
The global market for Left Atrial Appendage Occluder System was valued at US$ 345 million in the year 2024 and is projected to reach a revised size of US$ 474 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published Date: 2025-01-13
Pages: 80
USD 2900.00
(Single User License)
A Left Atrial Appendage Occluder System is a medical device used in the treatment of atrial fibrillation (AFib) to prevent blood clots from forming in the left atrial appendage of the heart. These devices are implanted to reduce the risk of stroke in patients with AFib who cannot tolerate long-term anticoagulation therapy.
Published Date: 2024-02-05
Pages: 88
USD 2900.00
(Single User License)
The global market for Left Atrial Appendage Occluder System was estimated to be worth US$ 360 million in 2025 and is projected to reach US$ 494 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 128
The global Left Atrial Appendage Occluder System market was valued at US$ 360 million in 2025 and is anticipated to reach US$ 494 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-04-17
Pages: 111
The global Left Atrial Appendage Occluder System market size was US$ 345 million in 2024 and is forecast to a readjusted size of US$ 474 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
The global Left Atrial Appendage Occluder System market is projected to grow from US$ 345 million in 2024 to US$ 474 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 146
The global market for Left Atrial Appendage Occluder System was valued at US$ 345 million in the year 2024 and is projected to reach a revised size of US$ 474 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published: 2025-01-13
Pages: 80
A Left Atrial Appendage Occluder System is a medical device used in the treatment of atrial fibrillation (AFib) to prevent blood clots from forming in the left atrial appendage of the heart. These devices are implanted to reduce the risk of stroke in patients with AFib who cannot tolerate long-term anticoagulation therapy.
Published: 2024-02-05
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now